KIF23 is a potential biomarker of diffuse large B cell lymphoma: Analysis based on bioinformatics and immunohistochemistry

Diffuse Large B Cell Lymphoma (DLBCL), the most common form of blood cancer. The genetic and clinical heterogeneity of DLBCL poses a major barrier to diagnosis and treatment. Hence, we aim to identify potential biomarkers for DLBCL. Differentially expressed genes were screened between DLBCL and the...

Descripción completa

Detalles Bibliográficos
Autores principales: Gong, Yuqi, Zhou, Lingna, Ding, Liya, Zhao, Jing, Wang, Zhe, Ren, Guoping, Zhang, Jing, Mao, Zhengrong, Zhou, Ren
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9276187/
https://www.ncbi.nlm.nih.gov/pubmed/35713434
http://dx.doi.org/10.1097/MD.0000000000029312

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9276187/
https://www.ncbi.nlm.nih.gov/pubmed/35713434
http://dx.doi.org/10.1097/MD.0000000000029312

Ejemplares similares